Non-profit scale Small to mid-size organization with 2-10 employees and revenue in the 1M–10M range, indicating potential for scaled but targeted partnerships and grant-focused deals rather than large enterprise contracts.

Duchenne focus Primary mission centers on Duchenne Muscular Dystrophy advocacy, research funding, and patient access, signaling opportunities to align with pharma, biotech, medical device suppliers, and research consortia that support rare disease initiatives.

Recent leadership New Director of Patient Access appointed, suggesting a willingness to engage in new collaborating programs, enrollment initiatives, and patient access strategies that could be leveraged for joint patient support offerings.

Advocacy & policy Active involvement in Washington advocacy and newborn screening discussions indicates potential for policy-focused funding programs, education campaigns, and sponsor-led stakeholder events.

Tech footprint Utilizes common non-profit tech stack (Microsoft 365, analytics tools) and standard web technologies, suggesting low to moderate integration needs for donor/datient engagement platforms, CRM enhancements, or digital marketing partnerships.